Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC)

Historical Holders from Q2 2015 to Q4 2025

Symbol
TDOC on NYSE
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
175,611,455
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
123,251,499
Holdings value
$953,032,883
% of all portfolios
0%
Number of holders
343
Number of buys
165
Number of sells
154
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $183,075,446 21,018,995 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 7.8% $99,368,053 13,556,351 BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025
As of 30 Sep 2025 Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) has 343 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 123,251,499 shares of 175,611,455 outstanding shares and own 70% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) own 54% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Holdings Value Nb Shares Share Change %
VANGUARD GROUP INC 12% $169,371,644 21,910,950 +4.2%
BlackRock, Inc. 7.9% $107,278,903 13,878,254 +0.31%
RENAISSANCE TECHNOLOGIES LLC 4.7% $63,206,989 8,176,842 +12%
DIMENSIONAL FUND ADVISORS LP 3.9% $53,260,110 6,889,194 +24%
Point72 Asset Management, L.P. 3.3% $44,550,635 5,763,342 -26%
STATE STREET CORP 2.7% $36,020,965 4,659,892 -6.4%
GEODE CAPITAL MANAGEMENT, LLC 2.4% $32,238,443 4,169,919 +0.48%
MORGAN STANLEY 2.1% $27,830,104 3,600,271 +84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% $19,650,054 2,542,051 -3.8%
GOLDMAN SACHS GROUP INC 1.4% $19,502,744 2,522,994 -3%
AMERIPRISE FINANCIAL INC 1.3% $17,660,705 2,284,697 +11%
Nuveen, LLC 1.1% $14,821,672 1,917,422 +58%
NORTHERN TRUST CORP 1% $14,052,452 1,817,911 +0.04%
Allianz Asset Management GmbH 0.92% $12,517,892 1,619,391 +189%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.86% $11,680,888 1,511,111 -26%
TWO SIGMA ADVISERS, LP 0.82% $11,128,239 1,439,617 -49%
TANG CAPITAL MANAGEMENT LLC 0.8% $10,822,000 1,400,000 0%
Invenomic Capital Management LP 0.78% $10,613,112 1,372,977 -5.1%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.71% $9,676,228 1,251,776 +25%
CITADEL ADVISORS LLC 0.69% $9,416,725 1,218,205 +33%
UBS Group AG 0.68% $9,289,791 1,201,784 +20%
TWO SIGMA INVESTMENTS, LP 0.64% $8,747,794 1,131,668 -48%
Quantinno Capital Management LP 0.63% $8,595,434 1,111,957 +86%
JANE STREET GROUP, LLC 0.62% $8,358,650 1,081,326 +382%
JUPITER ASSET MANAGEMENT LTD 0.56% $7,575,926 980,068

Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 16,323 $114,911 +$101,660 $7.02 2
2025 Q3 123,251,499 $953,032,883 -$43,926,987 $7.73 343
2025 Q2 127,657,050 $1,111,810,150 +$28,908,039 $8.71 348
2025 Q1 124,764,453 $993,137,558 -$13,210,237 $7.96 368
2024 Q4 126,600,183 $1,150,909,215 +$5,732,507 $9.09 366
2024 Q3 125,343,265 $1,150,235,748 -$100,725,771 $9.18 352
2024 Q2 138,653,865 $1,356,107,775 +$78,896,049 $9.78 389
2024 Q1 129,813,184 $1,959,292,768 +$8,558,227 $15.10 411
2023 Q4 128,213,716 $2,762,470,436 +$64,064,682 $21.55 425
2023 Q3 124,707,305 $2,318,095,592 -$112,449,287 $18.59 418
2023 Q2 128,734,634 $3,259,624,540 -$197,804,335 $25.32 418
2023 Q1 136,344,301 $3,528,176,976 +$69,660,076 $25.90 416
2022 Q4 134,795,560 $3,187,915,143 -$88,463,415 $23.65 419
2022 Q3 137,929,338 $3,500,590,930 -$132,587,746 $25.35 421
2022 Q2 142,508,101 $4,752,897,156 -$35,457,280 $33.21 492
2022 Q1 135,294,586 $9,760,150,727 -$44,236,110 $72.13 640
2021 Q4 135,661,577 $12,464,617,010 -$96,730,604 $91.82 689
2021 Q3 133,460,521 $16,925,944,366 +$674,213,489 $126.81 738
2021 Q2 127,751,069 $21,259,926,344 +$1,036,756,412 $166.29 807
2021 Q1 121,322,454 $22,048,095,012 +$973,044,719 $181.75 873
2020 Q4 109,175,126 $21,828,607,477 +$6,575,258,095 $199.96 869
2020 Q3 75,563,046 $16,555,972,646 +$917,790,340 $219.24 730
2020 Q2 71,460,376 $13,644,498,539 -$180,652,715 $190.84 654
2020 Q1 72,838,954 $11,295,952,445 -$2,132,897,022 $155.01 559
2019 Q4 87,035,459 $7,286,337,875 -$311,263,665 $83.72 404
2019 Q3 90,856,564 $6,151,556,774 +$311,350,683 $67.72 365
2019 Q2 86,279,161 $5,708,002,798 +$184,430,573 $66.41 360
2019 Q1 84,967,430 $4,724,239,062 +$201,451,274 $55.60 355
2018 Q4 81,502,841 $4,039,756,305 +$65,534,475 $49.57 321
2018 Q3 78,683,955 $6,793,917,690 +$279,097,203 $86.35 330
2018 Q2 76,024,459 $4,413,324,206 -$62,794,723 $58.05 272
2018 Q1 77,172,756 $3,107,046,518 +$70,245,035 $40.30 229
2017 Q4 75,618,965 $2,635,297,138 +$300,630,734 $34.85 204
2017 Q3 65,338,332 $2,166,327,928 +$268,095,591 $33.15 177
2017 Q2 57,326,616 $1,989,441,272 +$288,789,640 $34.70 165
2017 Q1 50,788,462 $1,269,721,925 +$612,842,037 $25.00 131
2016 Q4 28,818,430 $475,514,658 +$62,340,869 $16.50 107
2016 Q3 24,591,861 $450,136,800 +$92,859,707 $18.31 101
2016 Q2 18,488,436 $296,177,335 +$63,261,690 $16.02 85
2016 Q1 15,770,964 $151,754,000 -$36,741,446 $9.60 78
2015 Q4 18,650,348 $334,951,386 -$60,380,110 $17.96 73
2015 Q3 20,870,768 $457,767,253 +$452,106,452 $22.29 88
2015 Q2 266,265 $5,009,000 +$5,009,000 $19.00 14